The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Syphilis Immunoassay Diagnostics Market’s Market Value Anticipated To Evolve From 2026 To 2030?
The market size for syphilis immunoassay diagnostics has shown significant growth in recent years. It is anticipated to expand from $33.5 billion in 2025 to $36.05 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.6%. This historical expansion can be attributed to several factors, including the increasing incidence of sexually transmitted infections, the broadening of routine screening programs, enhancements in laboratory infrastructure, the accessibility of ELISA and CLIA technologies, and a heightened awareness of early syphilis diagnosis.
The syphilis immunoassay diagnostics market is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $46.91 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this growth during the forecast period include the greater uptake of rapid diagnostic tests, a heightened emphasis on decentralized testing approaches, broadened screening efforts in emerging economies, increasing investments in laboratory automation, and a rising need for high-throughput diagnostic platforms. Key trends anticipated during this period involve the wider adoption of automated immunoassay analyzers, a growing demand for highly sensitive diagnostic kits, the expansion of point-of-care syphilis testing, increasing integration of digital laboratory workflows, and an enhanced focus on prompt and precise disease detection.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16806&type=smp
Which Growth Factors Are Strengthening The Syphilis Immunoassay Diagnostics Market Landscape?
The increasing prevalence of sexually transmitted diseases is anticipated to drive the expansion of the syphilis immunoassay diagnostics market in the future. Sexually transmitted diseases (STDs), also referred to as sexually transmitted infections (STIs), are primarily infections transmitted via sexual contact, including vaginal, anal, and oral sexual activities. This increase in STDs can be attributed to factors such as reduced condom usage, growing antibiotic resistance, insufficient sexual education, evolving social and behavioral patterns, associated stigma, decreased funding for STD initiatives, and greater travel. Syphilis immunoassay diagnostics play a crucial role in detecting and managing sexually transmitted diseases, offering precise and prompt identification of syphilis infections, thereby facilitating suitable treatment and preventative actions. For example, in June 2024, a report by the Terrence Higgins Trust, a UK-based organization, indicated that the UK Health Security Agency (UKHSA) recorded 401,800 sexually transmitted infections (STIs) in England in 2023, marking a 5% increase from the year before. Consequently, the escalating number of sexually transmitted diseases is propelling the syphilis immunoassay diagnostics market.
Which Segment Groups Define The Syphilis Immunoassay Diagnostics Market Landscape?
The syphilis immunoassay diagnostics market covered in this report is segmented –
1) By Product: Analyzers, Reagents, Kits, Other Products
2) By Technology: Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Other Technologies
3) By Application: Men, Women
4) By End-User: Hospitals, Blood Banks, Diagnostics Labs, Other End-Users
Subsegments:
1) By Analyzers: Automated Analyzers, Semi-Automated Analyzers, Manual Analyzers
2) By Reagents: Enzyme-Linked Immunosorbent Assay Reagents, Chemiluminescent Immunoassay Reagents, Rapid Plasma Reagin Reagents, Treponemal And Non-Treponemal Reagents
3) By Kits: ELISA Kits, Rapid Diagnostic Test Kits, CLIA Kits, Point-Of-Care Test Kits
4) By Other Products: Control And Calibration Materials, Sample Collection Devices, Ancillary Testing Accessories
Which Trends Are Expected To Shape The Syphilis Immunoassay Diagnostics Market?
Leading companies within the synthetic biology market are prioritizing the development of innovative solutions, including custom programs designed for design-build-test cycles to accelerate specific synthetic biology initiatives. A custom solutions program offers a personalized service, allowing clients to collaborate directly with experts to design, build, and test synthetic DNA constructs, moving beyond standard off-the-shelf items. For example, in June 2025, Integrated DNA Technologies (IDT), a U.S.-based biotechnology company, introduced its Synthetic Biology Custom Solutions Program. This specialized manufacturing service provides customers access to IDT’s in-house scientists and engineers for tailored projects, encompassing everything from complex genes to non-standard DNA fragments. Key aspects include a dedicated team supporting design-build-test workflows, custom manufacturing conducted in IDT’s 25,000-sq-ft synthetic biology facility, broad acceptance of diverse project types (e.g., high-yield non-standard gene fragments, genes >5 kb, multi-site cloning), and quicker turnaround times due to the absence of rigid high-throughput restrictions. This program empowers synthetic biology innovators to accelerate iterations and overcome obstacles in their R&D efforts.
Who Are The Businesses Driving Activity In The Syphilis Immunoassay Diagnostics Market?
Major companies operating in the syphilis immunoassay diagnostics market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Siemens Healthineers, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, Meril Life Sciences Pvt Ltd, Randox Laboratories Ltd, SEKISUI Diagnostics, Trinity Biotech, Fujirebio, CTK Biotech Inc, bioLytical Laboratories Inc, ACON Laboratories Inc, InTec PRODUCTS INC, Quidel Corporation, Alere Inc, Ortho Clinical Diagnostics, DiaSorin Inc, Sekisui Medical, Beckman Coulter
Access The Complete Syphilis Immunoassay Diagnostics Market Report:
Which Regional Market Leads The Syphilis Immunoassay Diagnostics Market?
North America was the largest region in the syphilis immunoassay diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the syphilis immunoassay diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Syphilis Immunoassay Diagnostics Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=16806&type=smp
Browse Through More Reports Similar to the Global Syphilis Immunoassay Diagnostics Market 2026, By The Business Research Company
Immunodiagnostics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report
Infectious Disease Diagnostics Testing Global Market Report 2026
Diagnostic Specialty Antibodies Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model